CVS Health Corporation vs Merck & Company, Inc. — Stock Comparison
CVS Health Corporation (CVS) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
CVS Health Corporation narrowly edges Merck & Company, Inc. on Q·Score (7 vs 6.3 out of 10), led by Growth (8.2 vs 6.4) and Sentiment (8.5 vs 7.4). Merck & Company, Inc. scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for CVS (+24.9%) than for MRK (-0.5%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
89% of 27 covering analysts have a positive rating.
⚠ weak profitability metrics drag quality score.
71% of 28 covering analysts have a positive rating.
⚠ weak profitability metrics drag quality score.
Analyst Consensus
Fundamentals
Frequently Asked Questions
CVS vs MRK: which stock scores better overall?
Based on Q·Score, CVS Health Corporation (CVS) scores 7/10 versus Merck & Company, Inc. (MRK) at 6.3/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: CVS or MRK?
CVS Health Corporation (CVS) scores higher on Growth (8.2/10 vs 6.4/10). CVS Health Corporation reports revenue growth (7.1% YoY) while Merck & Company, Inc. reports (5.1% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is CVS or MRK more attractively valued?
CVS Health Corporation (CVS) scores higher on Valuation (7.5/10 vs 6.5/10). CVS trades at 10.9× P/E versus MRK at 15.7×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about CVS vs MRK?
There are 25 analysts covering CVS with a consensus price target of $116.08, and 26 analysts covering MRK with a consensus target of $148.73. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: CVS or MRK?
CVS Health Corporation (CVS) scores higher on Quality (5.2/10 vs 4.9/10). Net profit margin: CVS at 1.2%, MRK at 4.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: CVS or MRK?
Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 6.4/10). Market beta: CVS at 0.60, MRK at 0.21. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of CVS and MRK?
CVS Health Corporation (CVS) has a market capitalisation of $118.8B, while Merck & Company, Inc. (MRK) has a market cap of $368.9B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do CVS or MRK pay dividends?
CVS pays a dividend yield of 2.82%, while MRK pays a dividend yield of 2.22%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →